Locoid (hydrocortisone butyrate 0.1%)
Recall D-0026-2015, part of FDA recall event 69359. See Valeant Pharmaceuticals International's company page.
Valeant Pharmaceuticals International started this Class III drug recall on Oct 2, 2014 (voluntary: firm initiated); FDA lists it as terminated, terminated Apr 3, 2015.
- Classification: Class III
- Started: Oct 2, 2014
- Status: Terminated
- Products in this event: 2
Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 month stability test point
- Product
- Locoid (hydrocortisone butyrate 0.1%), Cream, Net Wt. 15 gm tubes, Rx only, Manufactured for: Onset Dermatologics, LLC, Cumberland, RI 02864 By: Ferndale Laboratories, Inc. Ferndale, MI 48220 --- NDC 16781-382-15
- Quantity
- 1663 tubes
- Lots and codes
- Lot number 13052B, Exp. 03/2015, NDC16781-382-15
- Distribution
- Nationwide and Puerto Rico
- Recalling firm
- Valeant Pharmaceuticals International, Bridgewater, NJ, United States
- How the firm notified
- Letter
- FDA classified
- Oct 16, 2014
- Hydrocortisone Butyrate Cream 0.1%, Net Wt. 15 gm tubes, Rx only, Manufactured for: Rouses Point Pharmaceuticals, LLC…D-0025-2015 · Class III · Oct 2, 2014 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports